| 摘要 |
<p>This invention relates to a process for the preparation of 1{5-(4-hydroxy-2H-1,2-benzothiazin-3-yl)-1,2,4-oxadiazol-3-yl!methyl}e thanone S,S-dioxide (III), a novel intermediate useful in the preparation of the known anti-inflammatory agent, 4-hydroxy-3-(5-methyl-3-isoxazolylcarbamoyl)-2-methyl-2H-1,2-benzothia zine 1,1-dioxide (IV). According to the process of this invention, the saccharin compound, 2,3-dihydro-N-(5-methyl-3-isoxazolyl)-3-oxo-1,2-benzisothiazole-2-acet amide 1,1-dioxide (I) is reacted with an alkali metal alkoxide of a lower alcohol in an inert solvent at temperatures below 30.degree.C. to form the benzenesulfonylglycineamide, alkyl 2-{({(5-methyl-3-isoxazolyl)amino!carbonyl}methyl)amino!sulfonyl}benzoate (II), which is ring closed and rearranged by reaction with an alkali metal alkoxide of a lower alcohol in an inert solvent at temperatures of from 60.degree.C. to 70.degree.C. to form the desired oxadiazole compound III.</p> |
